In accordance with Article 19 of the Market Abuse Regulation, notification is hereby given of transactions in the 10p ordinary shares of Halma by Directors and Persons Discharging Managerial Responsibilities (PDMRs), as set out below.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Steve Brown
2
Reason for the notification
a)
Position/status
Sector Chief Executive, Healthcare
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Halma plc
b)
LEI
2138007FRGLUR9KGBT40
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10p each in Halma plc
GB0004052071
b)
Nature of the transaction
(1) Vesting of Executive Share Plan Awards
(2) Sale of shares to cover tax
c)
Price(s) and volume(s)
Price(s)
Volume(s)
(1) £27.62
7,564
(2) £27.62
3,556
d)
Aggregated information
- Aggregated volume
- Price
- Total
11,120
£27.62
£307,134.40
e)
Date of the transaction
2024-11-26
f)
Place of the transaction
(1) Outside a trading venue & (2) XLON
A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com
Contact for further information:
Mark Jenkins
Company Secretary, Halma plc
Tel: +44 (0)1494 721111
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.